id,name,unit,description,createdAt,updatedAt,code,coverage,timespan,datasetId,sourceId,shortUnit,display,columnOrder,originalMetadata,grapherConfigAdmin,shortName,catalogPath,dimensions,schemaVersion,processingLevel,processingLog,titlePublic,titleVariant,attributionShort,attribution,descriptionShort,descriptionFromProducer,descriptionKey,descriptionProcessing,licenses,license,grapherConfigETL,type,sort,dataChecksum,metadataChecksum
519996,Indicator:General availability of urine strips for glucose and ketone measurement at the primary health care level,,,2022-08-30 15:09:51,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519989,Indicator:Existence of national guidelines for physical activity for adults,,"Definition: Indicates whether or not the country has national guidelines that provide recommended levels of physical activity for adults.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:51,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519987,Indicator:General availability of alteplase for acute stroke management in the public health system,,"Definition: Indicates whether or not the country has reported that alteplase for acute stroke management is generally available in the publicly funded health system.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:51,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519884,Indicator:Existence of price subsidies for healthy foods,,"Definition: Indicates whether or not the country has implemented price subsidies for healthy foods.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519857,Indicator:General availability of foot vibration perception by tuning fork at the primary health care level,,,2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519800,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of diabetes,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of diabetes through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519791,Indicator:Existence of national guidelines for physical activity,,"Definition: Indicates whether or not the country has national guidelines that provide recommended levels of physical activity for the population or a specific segment of the population.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519773,"Indicator:Has conducted a recent, national adult risk factor survey covering salt/sodium intake",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering salt/sodium intake.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519746,"Indicator:Has conducted a recent, national adult risk factor survey covering unhealthy diet",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering harmful alcohol use, physical inactivity, tobacco use, raised blood glucose/diabetes, raised total cholesterol, raised blood pressure/hypertension, overweight and obesity, salt-sodium intake or unhealthy diet.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519745,Indicator:Existence of a national target on diabetes,,"Definition: Indicates whether or not the country has set a national target addressing diabetes

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519740,Indicator:General availability of combination budesonide formoterol inhaler in the public health sector,,"Definition: Indicates whether or not the country has reported that combination budesonide-formoterol inhalers are generally available in primary health care facilities in the public health sector. ""Generally available"" is defined as ""in 50% or more pharmacies.""

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519739,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of overweight/obesity,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of overweight/obesity through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519737,Indicator:Existence of operational policy/strategy/action plan to reduce overweight/obesity,,"Definition: Indicates whether or not the country has an operational policy, strategy or action plan for reducing overweight/obesity.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519707,Indicator:General availability of Fixed dose combination avail (lisinopril + hydrochlorothiazide) in the public health sector,,"Definition: Indicates whether or not the country has reported that the fixed dose combination (lisinopril + hydrochlorothiazide) is generally available in primary health care facilities in the public health sector. ""Generally available"" is defined as ""in 50% or more pharmacies.""

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519703,Indicator:General availability of Fixed dose combination avail (telmisartan + amlodipine) in the public health sector,,"Definition: Indicates whether or not the country has reported that the fixed dose combination (telmisartan + amlodipine) is generally available in primary health care facilities in the public health sector. ""Generally available"" is defined as ""in 50% or more pharmacies.""

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519674,Indicator:Existence of a national target on blood pressure / hypertension,,"Definition: Indicates whether or not the country has set a national target addressing raised blood pressure.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519637,Indicator:Existence of a national target on salt,,"Definition: Indicates whether or not the country has set a national target addressing salt/sodium intake.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519628,Indicator:General availability of dilated fundus examination at the primary health care level,,,2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519627,Indicator:General availability of radiotherapy in the public sector,,"Definition: Indicates whether or not the country has reported that radiotherapy is generally available in the public sector. ""Generally available"" is defined as reaching 50% or more patients in need.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519587,Indicator:Existence of tax incentives to promote physical activity,,"Definition: Indicates whether or not the country has implemented taxation incentives to promote physical activity.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519584,Indicator:Existence of policy promoting physical activity: active ageing,,"Definition: Indicates whether or not the country has a national policy promoting active ageing.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519583,"Indicator:Has conducted a recent, national adult risk factor survey covering raised blood glucose/diabetes",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering raised blood glucose/diabetes.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519580,Indicator:General availability of Fixed dose combination avail (lisinopril + amlodipine) in the public health sector,,"Definition: Indicates whether or not the country has reported that the fixed dose combination (lisinopril + amlodipine) is generally available in primary health care facilities in the public health sector. ""Generally available"" is defined as ""in 50% or more pharmacies.""

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519574,Indicator:Existence of a national target on tobacco,,"Definition: Indicates whether or not the country has set a national target addressing tobacco use.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519572,Indicator:Implementation of a nutrition public awareness program,,"Definition: Indicates whether or not the country has implemented any national public education and awareness campaign on diet within the past 2 years.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519563,"Indicator:Has conducted a recent, national adult risk factor survey covering harmful alcohol use",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering harmful alcohol use.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519534,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of physical inactivity,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of physical inactivity through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:50,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519506,Indicator:General availability of pathology services (laboratories) in the public sector,,"Definition: Indicates whether or not the country has reported that pathology services (laboratories) are generally available in the public sector. ""Generally available"" is defined as reaching 50% or more patients in need.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519497,Indicator:Existence of operational policy/strategy/action plan for hearing health,,"Definition: Indicates whether or not the country has an operational policy, strategy or action plan for hearing health.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519472,Indicator:Existence of policy promoting physical activity: community-based and sports initiatives,,"Definition: Indicates whether or not the country has a national policy promoting community-based physical activity and sports initiatives.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519465,Indicator:Existence of national guidelines for physical activity for children under 5,,"Definition: Indicates whether or not the country has national guidelines that provide recommended levels of physical activity for children under 5.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519463,Indicator:General availability of cancer centres or cancer departments at tertiary level in the public sector,,"Definition: Indicates whether or not the country has reported that cancer centres or cancer departments at tertiary level are generally available in the public sector. ""Generally available"" is defined as reaching 50% or more patients in need.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519456,Indicator:General availability of cancer surgery in the public sector,,"Definition: Indicates whether or not the country has reported that cancer surgery is generally available in the public sector. ""Generally available"" is defined as reaching 50% or more patients in need.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519362,Indicator:Existence of a national target on obesity,,"Definition: Indicates whether or not the country has set a national target addressing obesity.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519346,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of tobacco dependence,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of tobacco dependence through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519314,Indicator:Implementation of a recent mass participation event,,"Definition: Indicates whether or not the country has implemented any national or subnational mass participation events to encourage participation by the general public in free opportunities for physical activity within the past 2 years.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519308,"Indicator:Has conducted a recent, national adult risk factor survey covering overweight and obesity",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering overweight and obesity.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519307,Indicator:Existence of a national target on physical inactivity,,"Definition: Indicates whether or not the country has set a national target addressing physical inactivity.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519306,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of cardiovascular diseases,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of cardiovascular diseases through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519299,Indicator:Existence of policy promoting physical activity: public open spaces,,"Definition: Indicates whether or not the country has a national policy promoting public open spaces (including parks) in order to promote physical activity.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519278,Indicator:General availability of diabetic retinopathy screening in the public health system,,"Definition: Indicates whether or not the country has reported that diabetic retinopathy screening is generally available in the publicly funded health system. ""Generally available"" is defined as reaching 50% or more patients in need.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519271,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of alcohol use disorders,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of alcohol use disorders through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519176,"Indicator:Has conducted a recent, national adult risk factor survey covering raised blood pressure/hypertension",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering raised blood pressure.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519175,Indicator:General availability of blood pressure measurement at the primary health care level,,,2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519150,Indicator:Existence of policy promoting physical activity: childcare settings,,"Definition: Indicates whether or not the country has a national policy promoting physical activity in childcare settings.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519147,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of cancer,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of cancer through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519144,Indicator:Existence of national guidelines for physical activity for children and adolescents aged 5-19,,"Definition: Indicates whether or not the country has national guidelines that provide recommended levels of physical activity for children and adolescents aged 5 to 19 years.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519138,Indicator:Existence of operational policy/strategy/action plan for eye health,,"Definition: Indicates whether or not the country has an operational policy, strategy or action plan for eye health.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519135,"Indicator:Existence of tax on foods high in fat, sugars or salt",,"Definition: Indicates whether or not the country has implemented taxation on foods high in fat, sugars or salt.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519133,Indicator:General availability of Fixed dose combination avail (telmisartan + hydrochlorothiazide) in the public health sector,,"Definition: Indicates whether or not the country has reported that the fixed dose combination (telmisartan + hydrochlorothiazide) is generally available in primary health care facilities in the public health sector. ""Generally available"" is defined as ""in 50% or more pharmacies.""

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:49,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519032,Indicator:Existence of a national target on drug therapy and counselling,,"Definition: Indicates whether or not the country has set a national target addressing drug therapy to prevent heart attacks and strokes.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
519031,"Indicator:Has conducted a recent, national adult risk factor survey covering raised total cholesterol",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering raised total cholesterol.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518987,Indicator:Existence of policy promoting physical activity: walking and cycling,,"Definition: Indicates whether or not the country has a national policy to promote walking and cycling.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518986,"Indicator:Has conducted a recent, national adult risk factor survey covering physical inactivity",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering physical inactivity.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518985,Indicator:Existence of a national target on alcohol,,"Definition: Indicates whether or not the country has set a national target addressing the harmful use of alcohol.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518982,Indicator:Existence of national guidelines for physical activity for older adults,,"Definition: Indicates whether or not the country has national guidelines that provide recommended levels of physical activity for older adults.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518977,"Indicator:Has conducted a recent, national adult risk factor survey covering tobacco use",,"Definition: Indicates whether or not the country has conducted a recent (i.e. in the past 5 years), national adult risk factor survey covering tobacco use.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518939,Indicator:Existence of a national target on essential medicines and technologies,,"Definition: Indicates whether or not the country has set a national target addressing availability of essential noncommunicable disease medicine and basic technologies to treat major noncommunicable diseases.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518915,Indicator:Existence of policy promoting physical activity: workplace initiatives,,"Definition: Indicates whether or not the country has a national policy promoting workplace physical activity initiatives.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518874,Indicator:Existence of a national target on NCD mortality,,"Definition: Indicates whether or not the country has set a national target on NCD mortality.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
518873,Indicator:Existence of evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseases,,"Definition: Indicates whether or not the country has evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseases through a primary care approach recognized/approved by government or competent authorities.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:48,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
515956,Indicator:General availability of spirometry at the primary health care level,,"Definition: Indicates whether or not the country has peak flow measurement spirometry generally available at the primary health care level, either in the public or private sector or both

Method of estimation: Official country response to WHO NCD Country Capacity Survey",2022-08-30 15:09:41,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
515946,Indicator:General availability of peak flow measurement at the primary health care level,,,2022-08-30 15:09:41,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
515917,Indicator:General availability of chemotherapy in the public sector,,"Definition: Indicates whether or not the country has reported that chemotherapy is generally available in the public sector. ""Generally available"" is defined as reaching 50% or more patients in need.

Method of estimation: Official country response to the WHO NCD Country Capacity Survey",2022-08-30 15:09:41,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
515222,Indicator:Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission,,"Rationale: The risk for mother-to-child transmission can be reduced significantly by the complementary approaches
of providing antiretroviral drugs (as treatment or as prophylaxis) to the mother and antiretroviral
prophylaxis to the infant and using safe delivery practices and safer infant feeding.

Definition: Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods

Method of estimation: The number of pregnant women living with HIV who need antiretroviral medicine for preventing mother-to-child transmission
is estimated using standardized statistical modelling based on UNAIDS/WHO methods that consider various epidemic and
demographic parameters and the national programme coverage of antiretroviral therapy in the country, such as the HIV prevalence
among women of reproductive age and the effect of HIV on fertility and antiretroviral therapy coverage. These statistical modelling
procedures are used to derive a comprehensive population-based estimate of the total number of pregnant women living with HIV who need antiretroviral medicine for preventing mother-to-child transmission in the country.",2022-08-30 15:09:40,2023-06-15 05:05:42,,,1990 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
515220,Indicator:Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission,,"Rationale: The risk for mother-to-child transmission can be reduced significantly by the complementary approaches of providing antiretroviral drugs (as treatment or as prophylaxis) to the mother and antiretroviral prophylaxis to the infant and using safe delivery practices and safer infant feeding.
The data will be used to track progress toward global and national goals towards elimination of mothert-to-child transmission; to inform policy and strategic planning; for advocacy; and leveraging resources for accelerated scale up.

Definition: Number of HIV-positive pregnant women who received antiretroviral drugs
during the past 12 months to reduce mother-to-child transmission.

Method of estimation: Programme monitoring: facility-based antiretroviral therapy registers or drug supply management systems.",2022-08-30 15:09:40,2023-06-15 05:05:42,,,2010 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471855,Indicator:Population without primary reliance on clean fuels and technologies for cooking (in millions) - Residence Area Type:Total,,"Rationale: The use of solid fuels and kerosene in households is associated with increased mortality from acute lower respiratory, chronic obstructive pulmonary disease, stroke, ischaemic heart disease, and lung cancer.
Definition: The population who are not able to rely on clean fuels and technologies as the primary source of domestic energy for cooking.
Method of measurement: The indicator is calculated as the total population minus the number of people using clean fuels and technologies. Based on the recommendations included in the WHO Guidelines for indoor air quality: household fuel combustion, the fuels and technologies that are considered clean include electricity, natural gas, liquified petroleum gas, biogas, ethanol, and solar.
Method of estimation: Modelled estimates. A non-parametrical statistical model based on household survey data and time as inputs is applied to derive estimates. For further information on the model, see Stoner O et al, 2020: Global Household Energy Model: A Multivariate Hierarchical Approach to Estimating Trends in the Use of Polluting and Clean Fuels for Cooking (see link below).
Input data for the model is found in the WHO Household Energy Database. This database compiles data from nationally-representative surveys and censuses that provide estimates of primary cooking fuels and technologies. In cases where estimates of the population not cooking at home, with missing data or cooking with other fuels are provided, these populations are removed from the denominator for estimation purposes. The population data is calculated by OWID and is available at: https://ourworldindata.org/grapher/population-past-future ",2022-08-05 09:45:23,2023-06-15 05:05:42,,,1990 - 2020,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471854,Indicator:Proportion of population without primary reliance on clean fuels and technologies for cooking (%) - Residence Area Type:Total,%,"Rationale: The use of solid fuels and kerosene in households is associated with increased mortality from acute lower respiratory, chronic obstructive pulmonary disease, stroke, ischaemic heart disease, and lung cancer.
Definition: Proportion of population without primary reliance on clean fuels and technology is calculated as the number of people unable to use clean fuels and technologies for cooking, heating and lighting divided by total population reporting that any cooking, heating or lighting, expressed as percentage. “Clean” is defined by the emission rate targets and specific fuel recommendations (i.e. against unprocessed coal and kerosene) included in the normative guidance WHO guidelines for indoor air quality: household fuel combustion. 
Method of measurement: The indicator is calculated as the number of people unable to use clean fuels and technologies divided by total population, expressed as a percentage. Based on the recommendations included in the WHO Guidelines for indoor air quality: household fuel combustion, the fuels and technologies that are considered clean include electricity, natural gas, liquified petroleum gas, biogas, ethanol, and solar. Method of estimation: A non-parametrical statistical model based on household survey data and time as inputs is applied to derive estimates. For further information on the model, see Stoner O et al, 2020: Global Household Energy Model: A Multivariate Hierarchical Approach to Estimating Trends in the Use of Polluting and Clean Fuels for Cooking (see link below). Input data for the model is found in the WHO Household Energy Database. This database compiles data from nationally-representative surveys and censuses that provide estimates of primary cooking fuels and technologies. In cases where estimates of the population not cooking at home, with missing data or cooking with other fuels are provided, these populations are removed from the denominator for estimation purposes. The population data source is the 2018 Revision of World Urbanization Prospects.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,1990 - 2020,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471853,Indicator:Neonatal tetanus - number of reported cases per million,,"Definition: Confirmed neonatal tetanus cases per million.

Method of estimation: WHO compiles neonatal tetanus data as reported by national authorities. Our World In Data converts this into a rate by standardising with our population variable.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,1974 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471852,Indicator:Yaws status of endemicity and number of cases,,Definition: The number of reported yaws cases combined with the status of endemicity dataset for all countries that had reported case numbers.,2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471851,Indicator:Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N),,"Rationale: Intake of trans-fatty acids (TFA) is associated with increased risk of heart attacks and death from coronary heart disease. Replacing industrially produced TFA with healthier oils and fats is cost-effective and feasible, and can be done without changing the taste of food or its cost to the consumer.
In May 2018, WHO called for the global elimination of industrially produced TFA by 2023 and released the REPLACE action framework to support countries in implementing the prompt, complete and sustained elimination of industrially produced TFA from the food supply. In May 2019, WHO released six REPLACE modules, which provide practical, step-by-step implementation guidance to support country actions. WHO recommends that countries adopt and implement one of two best-practice policy options for eliminating industrially produced TFA from the global food supply.

Definition: Country has a policy(ies) or regulatory measure(s) that limit industrially produced TFA in all settings and are in line with the recommended approach. The two best-practice policies for TFA elimination are: 1) mandatory national limit of 2 grams of industrially produced TFA per 100 grams of total fat in all foods; and 2) mandatory national ban on the production or use of partially hydrogenated oils (PHO) as an ingredient in all foods.
“Yes” if a best-practice is implemented, “No” if a best-practice is not implemented, or “－“ if there is no data.
If a country has adopted a best-practice policy, but the policy has not yet come into effect, ""Yes"" is inserted under the expected future year when the policy comes into effect.

Method of estimation: The indicator is based on TFA country score card available in the WHO Global database on the Implementation of Nutrition Action (GINA) (https://extranet.who.int/nutrition/gina/en/scorecard/TFA).",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2004 - 2022,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471850,Indicator:Number of isolates tested for cefixime,,,2022-08-05 09:45:23,2023-06-15 05:05:42,,,2009 - 2018,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471849,Indicator:Overall compliance with regulations on smoke-free environments (score),,"Definition: The level of compliance with the law was measured by asking in-country experts to provide their assessments by interview. These experts included at least three, and up to five, of the following persons:
• the most senior government official in charge of tobacco control or tobacco-related conditions;
• the head of a prominent NGO dedicated to tobacco control;
• a health professional (e.g. physician, nurse, pharmacist) specializing in tobacco-related conditions;
• a staff member of a public health university department;
• the Tobacco Free Initiative focal point at the WHO country office.
Assessments were requested for each provision which is in place under a national law banning smoking in public places and enclosed workplaces. Provisions not in place, or provisions put in place too recently to assess, were excluded from the request. An assessment of overall compliance with the law (all provisions considered together) was also requested.
The provisions of interest for assessing compliance with smoke-free environment laws are:
1. A complete ban on smoking in health care facilities
2. A complete ban on smoking in educational facilities (excluding universities)
3. A complete ban on smoking in universities
4. A complete ban on smoking in government facilities
5. A complete ban on smoking in indoor private offices and workplaces
6. A complete ban on smoking in restaurants
7. A complete ban on smoking in pubs and bars
8. A complete ban on smoking in public transport.
A compliance score of 0-10 was calculated based on the average responses of the 3-5 experts. If all experts said compliance was ""high"", a score of 10 was achieved. If all experts said compliance was ""minimal"", this resulted in a score of zero. A mix of high, moderate and minimal responses resulted in an average score calculated out of 10. Missing responses were scored as ""missing"" unless there were at least 3 non-missing responses given.

Method of estimation: Country reported data.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471848,Indicator:Prevalence of daily e-cigarette use among adults (%) - Sex:Both sexes,%,"Rationale: Crude prevalence rates can be used to assess the actual use of e-cigarettes in a country and to generate an estimate of the number of e-cigarette users in the population.

Definition: The crude rate, expressed as a percentage of the total population, refers to the number of current users of e-cigarettes per 100 population of the country. When this crude prevalence rate is multiplied by the country’s population, the result is the number of current users of e-cigarettes in the country. The definition of ""current"" varies between surveys, but often means use of e-cigarettes at least once during a defined period leading up to the survey date. E-cigarettes are defined differently in national surveys, but can be generally described as electronic nicotine delivery systems that do not contain tobacco.

Method of estimation: Country reported data.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471847,Indicator:Prevalence of daily e-cigarette use among adults (%) - Sex:Female,%,"Rationale: Crude prevalence rates can be used to assess the actual use of e-cigarettes in a country and to generate an estimate of the number of e-cigarette users in the population.

Definition: The crude rate, expressed as a percentage of the total population, refers to the number of current users of e-cigarettes per 100 population of the country. When this crude prevalence rate is multiplied by the country’s population, the result is the number of current users of e-cigarettes in the country. The definition of ""current"" varies between surveys, but often means use of e-cigarettes at least once during a defined period leading up to the survey date. E-cigarettes are defined differently in national surveys, but can be generally described as electronic nicotine delivery systems that do not contain tobacco.

Method of estimation: Country reported data.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471846,Indicator:Prevalence of daily e-cigarette use among adults (%) - Sex:Male,%,"Rationale: Crude prevalence rates can be used to assess the actual use of e-cigarettes in a country and to generate an estimate of the number of e-cigarette users in the population.

Definition: The crude rate, expressed as a percentage of the total population, refers to the number of current users of e-cigarettes per 100 population of the country. When this crude prevalence rate is multiplied by the country’s population, the result is the number of current users of e-cigarettes in the country. The definition of ""current"" varies between surveys, but often means use of e-cigarettes at least once during a defined period leading up to the survey date. E-cigarettes are defined differently in national surveys, but can be generally described as electronic nicotine delivery systems that do not contain tobacco.

Method of estimation: Country reported data.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471845,Indicator:Year of latest adult prevalence survey (nonsmoked),,"Rationale: Data on smoking prevalence and patterns of tobacco use among adults and youth that are both recent and representative of the national population are key to successful guidance of tobacco control programmes.

Definition: The survey is representative of the country's population aged in the range covered by the survey.

Method of estimation: None",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471844,Indicator:Estimate of current tobacco smoking prevalence (%) (age-standardized rate) - Sex:Female,%,"Rationale: Tobacco use is a major contributor to illness and death from non-communicable diseases (NCDs). There is no proven safe level of tobacco use or of second-hand smoke exposure. All daily and non-daily users of tobacco are at risk of a variety of poor health outcomes across the life-course, including NCDs. Reducing the prevalence of current tobacco use will make a large contribution to reducing premature mortality from NCDs. Routine and regular monitoring of this indicator is necessary to enable accurate monitoring and evaluation of the impact of implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC), or tobacco control policies in the countries that are not yet Parties to the WHO FCTC, over time.

Definition: The percentage of the population aged 15 years and over who currently use any smoked tobacco product, as estimated using the method described in the Method of Estimation below. “Current” means either daily or non-daily (occasional) use at the time of the survey. Smoked tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and any other form of smoked tobacco. Smoked tobacco products exclude smokeless (oral and nasal) tobacco products and products that do not contain tobacco, such as electronic nicotine delivery system (ENDS) of which e-cigarettes are a common type, as well as “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. Age-standardization is a method to adjust a country's prevalence rate using the WHO standard population (applied to age-specific prevalence rates) which allows meaningful comparison of rates between countries.

Method of estimation: A statistical model based on a Bayesian negative binomial meta-regression is used to model prevalence of current tobacco smoking for each country, separately for men and women. A full description of the method is available as a peer-reviewed article in The Lancet, volume 385, No. 9972, p966–976 (2015). Once the age-and-sex-specific prevalence rates from national surveys were compiled into a dataset, the model was fit to calculate trend estimates from the year 2000 to 2030. The model has two main components: (a) adjusting for missing indicators and age groups, and (b) generating an estimate of trends over time as well as the 95% credible interval around the estimate. Depending on the completeness/comprehensiveness of survey data from a particular country, the model at times makes use of data from other countries to fill information gaps. To fill data gaps, information is “borrowed” from countries in the same UN subregion. The resulting trend lines are used to derive estimates for single years, so that a number can be reported even if the country did not run a survey in that year. In order to make the results comparable between countries, the prevalence rates are age-standardized to the WHO Standard Population.
Estimates for countries with irregular surveys or many data gaps will have large uncertainty ranges, and such results should be interpreted with caution.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2000 - 2025,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471843,Indicator:Estimate of current tobacco smoking prevalence (%) (age-standardized rate) - Sex:Male,%,"Rationale: Tobacco use is a major contributor to illness and death from non-communicable diseases (NCDs). There is no proven safe level of tobacco use or of second-hand smoke exposure. All daily and non-daily users of tobacco are at risk of a variety of poor health outcomes across the life-course, including NCDs. Reducing the prevalence of current tobacco use will make a large contribution to reducing premature mortality from NCDs. Routine and regular monitoring of this indicator is necessary to enable accurate monitoring and evaluation of the impact of implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC), or tobacco control policies in the countries that are not yet Parties to the WHO FCTC, over time.

Definition: The percentage of the population aged 15 years and over who currently use any smoked tobacco product, as estimated using the method described in the Method of Estimation below. “Current” means either daily or non-daily (occasional) use at the time of the survey. Smoked tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and any other form of smoked tobacco. Smoked tobacco products exclude smokeless (oral and nasal) tobacco products and products that do not contain tobacco, such as electronic nicotine delivery system (ENDS) of which e-cigarettes are a common type, as well as “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. Age-standardization is a method to adjust a country's prevalence rate using the WHO standard population (applied to age-specific prevalence rates) which allows meaningful comparison of rates between countries.

Method of estimation: A statistical model based on a Bayesian negative binomial meta-regression is used to model prevalence of current tobacco smoking for each country, separately for men and women. A full description of the method is available as a peer-reviewed article in The Lancet, volume 385, No. 9972, p966–976 (2015). Once the age-and-sex-specific prevalence rates from national surveys were compiled into a dataset, the model was fit to calculate trend estimates from the year 2000 to 2030. The model has two main components: (a) adjusting for missing indicators and age groups, and (b) generating an estimate of trends over time as well as the 95% credible interval around the estimate. Depending on the completeness/comprehensiveness of survey data from a particular country, the model at times makes use of data from other countries to fill information gaps. To fill data gaps, information is “borrowed” from countries in the same UN subregion. The resulting trend lines are used to derive estimates for single years, so that a number can be reported even if the country did not run a survey in that year. In order to make the results comparable between countries, the prevalence rates are age-standardized to the WHO Standard Population.
Estimates for countries with irregular surveys or many data gaps will have large uncertainty ranges, and such results should be interpreted with caution.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2000 - 2025,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471842,Indicator:Estimate of current tobacco smoking prevalence (%) (age-standardized rate) - Sex:Both sexes,%,"Rationale: Tobacco use is a major contributor to illness and death from non-communicable diseases (NCDs). There is no proven safe level of tobacco use or of second-hand smoke exposure. All daily and non-daily users of tobacco are at risk of a variety of poor health outcomes across the life-course, including NCDs. Reducing the prevalence of current tobacco use will make a large contribution to reducing premature mortality from NCDs. Routine and regular monitoring of this indicator is necessary to enable accurate monitoring and evaluation of the impact of implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC), or tobacco control policies in the countries that are not yet Parties to the WHO FCTC, over time.

Definition: The percentage of the population aged 15 years and over who currently use any smoked tobacco product, as estimated using the method described in the Method of Estimation below. “Current” means either daily or non-daily (occasional) use at the time of the survey. Smoked tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and any other form of smoked tobacco. Smoked tobacco products exclude smokeless (oral and nasal) tobacco products and products that do not contain tobacco, such as electronic nicotine delivery system (ENDS) of which e-cigarettes are a common type, as well as “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. Age-standardization is a method to adjust a country's prevalence rate using the WHO standard population (applied to age-specific prevalence rates) which allows meaningful comparison of rates between countries.

Method of estimation: A statistical model based on a Bayesian negative binomial meta-regression is used to model prevalence of current tobacco smoking for each country, separately for men and women. A full description of the method is available as a peer-reviewed article in The Lancet, volume 385, No. 9972, p966–976 (2015). Once the age-and-sex-specific prevalence rates from national surveys were compiled into a dataset, the model was fit to calculate trend estimates from the year 2000 to 2030. The model has two main components: (a) adjusting for missing indicators and age groups, and (b) generating an estimate of trends over time as well as the 95% credible interval around the estimate. Depending on the completeness/comprehensiveness of survey data from a particular country, the model at times makes use of data from other countries to fill information gaps. To fill data gaps, information is “borrowed” from countries in the same UN subregion. The resulting trend lines are used to derive estimates for single years, so that a number can be reported even if the country did not run a survey in that year. In order to make the results comparable between countries, the prevalence rates are age-standardized to the WHO Standard Population.
Estimates for countries with irregular surveys or many data gaps will have large uncertainty ranges, and such results should be interpreted with caution.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2000 - 2025,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471841,Indicator:Existence of national radon action plan - Years covered,,"Definition: The time period covered by the current national radon action plan. <br> Response options include a starting year and ending year.

Method of estimation: Country response to WHO Radon Survey 2018",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2019 - 2021,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471840,Indicator:Persistence to last grade of primary (% of cohort) - Sex:Both sexes,,"Rationale: The cohort survival rate measures an education system's holding power and internal efficiency. Rates approaching 100 percent indicate high retention and low dropout levels.

Definition: Persistence to last grade of primary is the percentage of children enrolled in the first grade of primary school who eventually reach the last grade of primary education. The estimate is based on the reconstructed cohort method. Persistence to last grade of primary is the percentage of children enrolled in the first grade of primary school who eventually reach the last grade of primary education. The estimate is based on the reconstructed cohort method.

Method of measurement: Cohort survival rate is calculated by dividing the total number of children belonging to a cohort who reached each successive grade of the specified level of education by the number of children in the same cohort; those originally enrolled in the first grade of primary education, and multiplying by 100. To reflect current patterns of grade transition, it is calculated based on the reconstructed cohort method, which uses data on enrollment by grade for the two most recent years and data on repeaters by grade for the most recent of those two years. Data on education are collected by the UNESCO Institute for Statistics from official responses to its annual education survey. All the data are mapped to the International Standard Classification of Education (ISCED) to ensure the comparability of education programs at the international level. The current version was formally adopted by UNESCO Member States in 2011. The reference years reflect the school year for which the data are presented. In some countries the school year spans two calendar years (for example, from September 2010 to June 2011); in these cases the reference year refers to the year in which the school year ended (2011 in the example).

Method of estimation: UNESCO compiles data on net primary school enrollment ratio.

Method of measurement: Aggregation method: Weighted average",2022-08-05 09:45:23,2023-06-15 05:05:42,,,1990 - 2018,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471839,Indicator:Persistence to last grade of primary (% of cohort) - Sex:Female,,"Rationale: The cohort survival rate measures an education system's holding power and internal efficiency. Rates approaching 100 percent indicate high retention and low dropout levels.

Definition: Persistence to last grade of primary is the percentage of children enrolled in the first grade of primary school who eventually reach the last grade of primary education. The estimate is based on the reconstructed cohort method. Persistence to last grade of primary is the percentage of children enrolled in the first grade of primary school who eventually reach the last grade of primary education. The estimate is based on the reconstructed cohort method.

Method of measurement: Cohort survival rate is calculated by dividing the total number of children belonging to a cohort who reached each successive grade of the specified level of education by the number of children in the same cohort; those originally enrolled in the first grade of primary education, and multiplying by 100. To reflect current patterns of grade transition, it is calculated based on the reconstructed cohort method, which uses data on enrollment by grade for the two most recent years and data on repeaters by grade for the most recent of those two years. Data on education are collected by the UNESCO Institute for Statistics from official responses to its annual education survey. All the data are mapped to the International Standard Classification of Education (ISCED) to ensure the comparability of education programs at the international level. The current version was formally adopted by UNESCO Member States in 2011. The reference years reflect the school year for which the data are presented. In some countries the school year spans two calendar years (for example, from September 2010 to June 2011); in these cases the reference year refers to the year in which the school year ended (2011 in the example).

Method of estimation: UNESCO compiles data on net primary school enrollment ratio.

Method of measurement: Aggregation method: Weighted average",2022-08-05 09:45:23,2023-06-15 05:05:42,,,1990 - 2018,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471838,Indicator:Persistence to last grade of primary (% of cohort) - Sex:Male,,"Rationale: The cohort survival rate measures an education system's holding power and internal efficiency. Rates approaching 100 percent indicate high retention and low dropout levels.

Definition: Persistence to last grade of primary is the percentage of children enrolled in the first grade of primary school who eventually reach the last grade of primary education. The estimate is based on the reconstructed cohort method. Persistence to last grade of primary is the percentage of children enrolled in the first grade of primary school who eventually reach the last grade of primary education. The estimate is based on the reconstructed cohort method.

Method of measurement: Cohort survival rate is calculated by dividing the total number of children belonging to a cohort who reached each successive grade of the specified level of education by the number of children in the same cohort; those originally enrolled in the first grade of primary education, and multiplying by 100. To reflect current patterns of grade transition, it is calculated based on the reconstructed cohort method, which uses data on enrollment by grade for the two most recent years and data on repeaters by grade for the most recent of those two years. Data on education are collected by the UNESCO Institute for Statistics from official responses to its annual education survey. All the data are mapped to the International Standard Classification of Education (ISCED) to ensure the comparability of education programs at the international level. The current version was formally adopted by UNESCO Member States in 2011. The reference years reflect the school year for which the data are presented. In some countries the school year spans two calendar years (for example, from September 2010 to June 2011); in these cases the reference year refers to the year in which the school year ended (2011 in the example).

Method of estimation: UNESCO compiles data on net primary school enrollment ratio.

Method of measurement: Aggregation method: Weighted average",2022-08-05 09:45:23,2023-06-15 05:05:42,,,1990 - 2018,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471837,Indicator:Total number of  malaria cases (presumed + confirmed cases),,"Definition: Malaria cases (presumed and confirmed) from all reporting sectors (public/private/community) throughout the country. Confirmed cases are malaria cases in which the parasite has been detected in a diagnostic test i.e microscopy, RDT or molecular diagnostic test. Presumed cases are cases suspected of being malaria that are not confirmed by a diagnostic test.

Method of measurement: Data submitted by the national malaria control programmes (NMCPs) compiled by WHO.
Method of calculation:
Confirmed cases used were reported through the laboratory, unless indicated by the country that confirmed cases should be used from the outpatient register owing to incomplete or inaccurate laboratory data. Confirmed cases were corrected for double counting of microscopy and RDT where the exact number of double counted cases was known. Confirmed cases include indigenous, imported, introduced, relapsing and recrudescent cases, as well as all species, including non-human malaria P. knowlesi. Presumed cases are reported from the outpatient register. Total cases are the sum of confirmed and presumed cases.

Method of estimation: N/A",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2010 - 2020,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471836,Indicator:Age range of most recent survey of adults,,"Rationale: In order to compare the results of different surveys, it is necessary to know the age range of respondents in each survey.

Definition: The age range of respondents sampled in the survey, given in years.

Method of estimation: Country reported data",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471835,Indicator:Prevalence of daily tobacco use among adults (%) - Sex:Both sexes,%,"Rationale: Crude prevalence rates can be used to assess the actual use of tobacco in a country and to generate an estimate of the number of tobacco users in the population.

Definition: The crude rate, expressed as a percentage of the total population, refers to the number of current users of any tobacco product per 100 population of the country. When this crude prevalence rate is multiplied by the country’s population, the result is the number of current users of any tobacco product in the country. The definition of ""current"" varies between surveys, but often means use of any tobacco product at least once during a defined period leading up to the survey date. Tobacco use includes use of cigarettes, cigars, pipes, waterpipes, heated tobacco products, any form of smokeless tobacco (chewed, sucked, nasal) and any other form of tobacco. Tobacco use excludes use of products that do not contain tobacco, such as electronic nicotine delivery system (ENDS) of which electronic cigarettes are a common type.

Method of estimation: Country reported data.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471834,Indicator:Prevalence of daily tobacco use among adults (%) - Sex:Female,%,"Rationale: Crude prevalence rates can be used to assess the actual use of tobacco in a country and to generate an estimate of the number of tobacco users in the population.

Definition: The crude rate, expressed as a percentage of the total population, refers to the number of current users of any tobacco product per 100 population of the country. When this crude prevalence rate is multiplied by the country’s population, the result is the number of current users of any tobacco product in the country. The definition of ""current"" varies between surveys, but often means use of any tobacco product at least once during a defined period leading up to the survey date. Tobacco use includes use of cigarettes, cigars, pipes, waterpipes, heated tobacco products, any form of smokeless tobacco (chewed, sucked, nasal) and any other form of tobacco. Tobacco use excludes use of products that do not contain tobacco, such as electronic nicotine delivery system (ENDS) of which electronic cigarettes are a common type.

Method of estimation: Country reported data.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471833,Indicator:Prevalence of daily tobacco use among adults (%) - Sex:Male,%,"Rationale: Crude prevalence rates can be used to assess the actual use of tobacco in a country and to generate an estimate of the number of tobacco users in the population.

Definition: The crude rate, expressed as a percentage of the total population, refers to the number of current users of any tobacco product per 100 population of the country. When this crude prevalence rate is multiplied by the country’s population, the result is the number of current users of any tobacco product in the country. The definition of ""current"" varies between surveys, but often means use of any tobacco product at least once during a defined period leading up to the survey date. Tobacco use includes use of cigarettes, cigars, pipes, waterpipes, heated tobacco products, any form of smokeless tobacco (chewed, sucked, nasal) and any other form of tobacco. Tobacco use excludes use of products that do not contain tobacco, such as electronic nicotine delivery system (ENDS) of which electronic cigarettes are a common type.

Method of estimation: Country reported data.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2018 - 2018,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471832,"Indicator:Prevalence of use of assistive products (%) - Age Group:All age groups (total) - Assistive technology product:Total, excluding spectacles",%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2019 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471831,Indicator:Prevalence of use of assistive products (%) - Age Group:All age groups (total) - Assistive technology product:Total,%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2019 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471830,"Indicator:Prevalence of use of assistive products (%) - Residence Area Type:Total - Assistive technology product:Total, excluding spectacles",%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2019 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471829,Indicator:Prevalence of use of assistive products (%) - Residence Area Type:Total - Assistive technology product:Total,%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2019 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471828,Indicator:Prevalence of use of assistive products (%) - Assistive technology product:White canes,%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471827,"Indicator:Prevalence of use of assistive products (%) - Assistive technology product:Wheelchairs, manual with postural support",%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471826,"Indicator:Prevalence of use of assistive products (%) - Assistive technology product:Wheelchairs, electrically powered",%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471825,"Indicator:Prevalence of use of assistive products (%) - Assistive technology product:Watches, talking/touching",%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471824,Indicator:Prevalence of use of assistive products (%) - Assistive technology product:Video communication devices,%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471823,Indicator:Prevalence of use of assistive products (%) - Assistive technology product:tricycles,%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,
471822,"Indicator:Prevalence of use of assistive products (%) - Assistive technology product:Travel aids, portable",%,"Rationale: The WHA71.8 Resolution on improving access to assistive technology urges all Member States to take actions to improve access to assistive technology, and requests WHO to develop progress reports to monitor the status of assistive technology access and communicate the progress made by Member States in implementing the resolution.

Definition: The proportion of a population using at least one assistive product.

Method of measurement: Population-based survey: household survey conducted with the rapid Assistive Technology Assessment (rATA), a dedicated WHO survey tool collecting self-reported data on access to assistive technology.

Method of estimation: Estimates derived from national household surveys using the rapid Assistive Technology Assessment (rATA).
Percentage of population using at least one assistive product = (Number of respondents who reported using at least one assistive product / Total number of respondents) * 100
Sample weighting was applied.",2022-08-05 09:45:23,2023-06-15 05:05:42,,,2021 - 2021,5676,26700,%,{},0,{},,,,,1,,,,,,,,,,,,,,,,,